[1]
Gülgün Tahan et al. 2019. Effects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats. Turkish Journal of Gastroenterology. 21, 3 (Jul. 2019), 287–292.